These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 16484770)
41. Spirometrically gated high-resolution CT findings in COPD: lung attenuation vs lung function and dyspnea severity. Camiciottoli G; Bartolucci M; Maluccio NM; Moroni C; Mascalchi M; Giuntini C; Pistolesi M Chest; 2006 Mar; 129(3):558-64. PubMed ID: 16537852 [TBL] [Abstract][Full Text] [Related]
42. Chronic effort dyspnea explained by lung function tests and by HRCT and CRX radiographic patterns in COPD: a post-hoc analysis in 51 patients. Giuntini C; Camiciottoli G; Maluccio NM; Mariani L; Lavorini F; Pistolesi M COPD; 2007 Sep; 4(3):169-76. PubMed ID: 17729059 [TBL] [Abstract][Full Text] [Related]
43. Correlations between blood vessel distribution, lung function and structural change in idiopathic pulmonary fibrosis. Hu PW; Chen CK; Hsiao YH; Weng CY; Lee YC; Su KC; Feng JY; Chou KT; Perng DW; Ko HK Respirology; 2024 Nov; 29(11):962-968. PubMed ID: 39147387 [TBL] [Abstract][Full Text] [Related]
44. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. Nishiyama O; Miyajima H; Fukai Y; Yamazaki R; Satoh R; Yamagata T; Sano H; Iwanaga T; Higashimoto Y; Nakajima H; Kume H; Tohda Y Respir Med; 2013 Aug; 107(8):1241-6. PubMed ID: 23806287 [TBL] [Abstract][Full Text] [Related]
45. [Idiopathic interstitial pneumonitis presenting with Wells grade III. Can imaging methods help predict further progression of disease?]. Fasano L; Zompatori M; Monetti N; Battista G; Pacilli AM; Scioscio V Di; Sciascia N Radiol Med; 1999 Oct; 98(4):268-74. PubMed ID: 10615366 [TBL] [Abstract][Full Text] [Related]
46. Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial. Manzetti GM; Hosein K; Cecchini MJ; Kwan K; Abdelrazek M; Zompatori M; Rogliani P; Mura M BMC Pulm Med; 2021 Dec; 21(1):396. PubMed ID: 34863146 [TBL] [Abstract][Full Text] [Related]
47. Quantitative CT analysis of honeycombing area in idiopathic pulmonary fibrosis: Correlations with pulmonary function tests. Nakagawa H; Nagatani Y; Takahashi M; Ogawa E; Tho NV; Ryujin Y; Nagao T; Nakano Y Eur J Radiol; 2016 Jan; 85(1):125-130. PubMed ID: 26724656 [TBL] [Abstract][Full Text] [Related]
48. [The assessment of the activity of idiopathic pulmonary fibrosis by high-resolution computed tomography]. Zompatori M; Fasano L; Rimondi MR; Poletti V; Pacilli AM; Battaglia M; Canini R; Stambazzi C Radiol Med; 1996 Mar; 91(3):238-46. PubMed ID: 8628937 [TBL] [Abstract][Full Text] [Related]
50. Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function. Jacob J; Bartholmai BJ; Rajagopalan S; Kokosi M; Nair A; Karwoski R; Raghunath SM; Walsh SL; Wells AU; Hansell DM J Thorac Imaging; 2016 Sep; 31(5):304-11. PubMed ID: 27262146 [TBL] [Abstract][Full Text] [Related]
51. A double blind randomised placebo controlled pilot study of oral co-trimoxazole in advanced fibrotic lung disease. Varney VA; Parnell HM; Salisbury DT; Ratnatheepan S; Tayar RB Pulm Pharmacol Ther; 2008; 21(1):178-87. PubMed ID: 17500020 [TBL] [Abstract][Full Text] [Related]
52. Volumetric characteristics of idiopathic pulmonary fibrosis lungs: computational analyses of high-resolution computed tomography images of lung lobes. Sul B; Flors L; Cassani J; Morris MJ; Reifman J; Altes T; Wallqvist A Respir Res; 2019 Oct; 20(1):216. PubMed ID: 31604436 [TBL] [Abstract][Full Text] [Related]
53. Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters? Taha N; D'Amato D; Hosein K; Ranalli T; Sergiacomi G; Zompatori M; Mura M Respir Res; 2020 May; 21(1):119. PubMed ID: 32429952 [TBL] [Abstract][Full Text] [Related]
54. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Kozu R; Senjyu H; Jenkins SC; Mukae H; Sakamoto N; Kohno S Respiration; 2011; 81(3):196-205. PubMed ID: 20516666 [TBL] [Abstract][Full Text] [Related]
55. Factors associated with dyspnea in adult patients with sickle cell disease. Delclaux C; Zerah-Lancner F; Bachir D; Habibi A; Monin JL; Godeau B; Galacteros F Chest; 2005 Nov; 128(5):3336-44. PubMed ID: 16304281 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Tzanakis N; Samiou M; Lambiri I; Antoniou K; Siafakas N; Bouros D Eur J Intern Med; 2005 Apr; 16(2):105-112. PubMed ID: 15833676 [TBL] [Abstract][Full Text] [Related]
57. Idiopathic pulmonary fibrosis vs. pulmonary involvement of collagen vascular disease: HRCT findings. Lim MK; Im JG; Ahn JM; Kim JH; Lee SK; Yeon KM; Han MC J Korean Med Sci; 1997 Dec; 12(6):492-8. PubMed ID: 9443086 [TBL] [Abstract][Full Text] [Related]
58. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Ogawa T; Watanabe F; Nishimura K Respir Med; 2005 Apr; 99(4):408-14. PubMed ID: 15763446 [TBL] [Abstract][Full Text] [Related]